Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5958
    +0.0021 (+0.35%)
     
  • NZD/EUR

    0.5552
    +0.0006 (+0.11%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.74
    -0.07 (-0.08%)
     
  • GOLD

    2,336.90
    -1.50 (-0.06%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,096.93
    +56.55 (+0.70%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,988.77
    -99.93 (-0.55%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.6790
    +0.5640 (+0.61%)
     

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

On May 9, Novavax (NASDAQ: NVAX) shareholders got a much-needed reprieve from the stock's downward trajectory over the last year. Novavax's decline is a regrettable one. Its coronavirus vaccine candidate ran into regulatory issues during clinical development, and arrived on the market much later than those of competitors like Pfizer and Moderna.